Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 2004, p. 651-654, Vol. 48, No. 2
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.2.651-654.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Inhibition of the Subgenomic Hepatitis C Virus Replicon in Huh-7 Cells by 2'-Deoxy-2'-Fluorocytidine
Lieven J. Stuyver,1,
Tamara R. McBrayer,1 Tony Whitaker,1 Phillip M. Tharnish,1 Mangala Ramesh,1 Stefania Lostia,1 Leanne Cartee,1 Junxing Shi,1 Ann Hobbs,1 Raymond F. Schinazi,2 Kyoichi A. Watanabe,1 and Michael J. Otto1*
Pharmasset, Inc., Tucker, Georgia 30084,1
Department of Pediatrics, Emory School of Medicine/Veterans Affairs Medical Center, Decatur, Georgia 300332
Received 17 June 2003/
Returned for modification 4 September 2003/
Accepted 14 October 2003
2'-Deoxy-2'-fluorocytidine (FdC) is a potent inhibitor of the hepatitis C virus RNA replicon in culture, and FdC-5'-triphosphate is an effective inhibitor of the NS5B polymerase. Dynamic profiling of cell growth in an antiviral assay showed that FdC caused cytostasis due to an S-phase arrest. These observations demonstrate that FdC treatment is affecting both a viral target and a cellular target.
* Corresponding author. Mailing address: Pharmasset Inc., 1860 Montreal Rd., Tucker, GA 30084. Phone: (678) 395-0050. Fax: (678) 395-0030. E-mail:
motto{at}pharmasset.com.
Present address: Virco BVBA, Mechelen, Belgium.
Antimicrobial Agents and Chemotherapy, February 2004, p. 651-654, Vol. 48, No. 2
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.2.651-654.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Heck, J. A., Lam, A. M. I., Narayanan, N., Frick, D. N.
(2008). Effects of Mutagenic and Chain-Terminating Nucleotide Analogs on Enzymes Isolated from Hepatitis C Virus Strains of Various Genotypes. Antimicrob. Agents Chemother.
52: 1901-1911
[Abstract]
[Full Text]
-
Klumpp, K., Kalayanov, G., Ma, H., Le Pogam, S., Leveque, V., Jiang, W.-R., Inocencio, N., De Witte, A., Rajyaguru, S., Tai, E., Chanda, S., Irwin, M. R., Sund, C., Winqist, A., Maltseva, T., Eriksson, S., Usova, E., Smith, M., Alker, A., Najera, I., Cammack, N., Martin, J. A., Johansson, N. G., Smith, D. B.
(2008). 2'-Deoxy-4'-azido Nucleoside Analogs Are Highly Potent Inhibitors of Hepatitis C Virus Replication Despite the Lack of 2'-{alpha}-Hydroxyl Groups. J. Biol. Chem.
283: 2167-2175
[Abstract]
[Full Text]
-
Klumpp, K., Leveque, V., Le Pogam, S., Ma, H., Jiang, W.-R., Kang, H., Granycome, C., Singer, M., Laxton, C., Hang, J. Q., Sarma, K., Smith, D. B., Heindl, D., Hobbs, C. J., Merrett, J. H., Symons, J., Cammack, N., Martin, J. A., Devos, R., Najera, I.
(2006). The Novel Nucleoside Analog R1479 (4'-Azidocytidine) Is a Potent Inhibitor of NS5B-dependent RNA Synthesis and Hepatitis C Virus Replication in Cell Culture. J. Biol. Chem.
281: 3793-3799
[Abstract]
[Full Text]
-
Ludmerer, S. W., Graham, D. J., Boots, E., Murray, E. M., Simcoe, A., Markel, E. J., Grobler, J. A., Flores, O. A., Olsen, D. B., Hazuda, D. J., LaFemina, R. L.
(2005). Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay. Antimicrob. Agents Chemother.
49: 2059-2069
[Abstract]
[Full Text]